Caption Management’s Immunogen Inc IMGN Stock Holding History

Caption Management’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-40,600	Closed	-$808K	–	1779
2023 Q3	$644K	Buy	40,600 +10,600	+35%	+$176K	0.01%	875
2023 Q2	$566K	Buy	+30,000	New	+$354K	0.01%	792
2021 Q3	–	Sell	-20,000	Closed	-$116K	–	1879
2021 Q2	$131K	Hold	20,000	–	–	﹤0.01%	1206
2021 Q1	$163K	Sell	20,000 -37,100	-65%	-$303K	﹤0.01%	936
2020 Q4	$368K	Buy	+57,100	New	+$333K	0.01%	780
2019 Q4	–	Sell	-50,000	Closed	-$121K	–	1037
2019 Q3	$121K	Sell	50,000 -30,000	-38%	-$79.7K	0.01%	630
2019 Q2	$174K	Buy	80,000 +78,800	+6,567%	+$186K	0.01%	577
2019 Q1	$3K	Sell	1,200 -169,550	-99%	-$734K	﹤0.01%	540
2018 Q4	$819K	Buy	170,750 +93,500	+121%	+$567K	0.07%	280
2018 Q3	$732K	Buy	+77,250	New	+$743K	0.04%	371

Other funds holding IMGN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Caption Management's IMGN Position: Q4 2023 in Review

Caption Management sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 40,600 shares — an estimated $808K sold.

Caption Management first reported a position in IMGN in Q3 2018 and held it in 10 quarters. The position peaked at $819K in Q4 2018. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

Caption Management reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
Caption Management sold 40,600 Immunogen Inc shares in Q4 2023, an estimated $808K.
Caption Management first reported a position in Immunogen Inc in Q3 2018 and held it in 10 quarters.
Caption Management's Immunogen Inc position peaked at $819K in Q4 2018.
327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on Caption Management's 13F filing for Q4 2023, filed 14 Feb 2024.